Finch Therapeutics Group Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
28 Mar 24 | SellUS$21,246 | Jeffery Smisek | Individual | 8,242 | US$2.61 | |
22 Nov 23 | SellUS$5,351 | Jeffery Smisek | Individual | 1,470 | US$3.64 | |
09 Jun 23 | BuyUS$1,353 | Susan Graf | Individual | 167 | US$8.10 |
Insider Trading Volume
Insider Buying: FNCH insiders have only sold shares in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 2,626 | 0.164% |
Institutions | 277,423 | 17.3% |
General Public | 515,440 | 32.1% |
Individual Insiders | 810,274 | 50.5% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
421,381 | US$977.6k | 0% | no data | |||
160,366 | US$372.0k | 37.5% | no data | |||
135,230 | US$313.7k | 0% | no data | |||
67,296 | US$156.1k | 0% | no data | |||
63,434 | US$147.2k | 0% | no data | |||
59,028 | US$136.9k | 0% | no data | |||
45,650 | US$105.9k | 0% | 0.25% | |||
40,260 | US$93.4k | 0% | no data | |||
38,764 | US$89.9k | 7.86% | no data | |||
21,206 | US$49.2k | 0% | no data | |||
11,746 | US$27.3k | 0% | no data | |||
6,892 | US$16.0k | 0% | no data | |||
6,512 | US$15.1k | -55.9% | no data | |||
6,163 | US$14.3k | -3.7% | no data | |||
2,626 | US$6.1k | 498% | no data | |||
1,045 | US$2.4k | 0% | no data | |||
971 | US$2.3k | 0% | no data | |||
933 | US$2.2k | 0% | no data | |||
341 | US$791.3 | 0% | no data | |||
167 | US$387.4 | 0% | no data | |||
141 | US$327.1 | 0% | no data | |||
123 | US$285.4 | 0% | no data | |||
27 | US$62.6 | 0% | no data | |||
12 | US$27.9 | 0% | no data | |||
6 | US$13.8 | 0% | no data |